Cases & Deals

  • Home
  • Practices
  • Feedback Therapeutics negotiates license agreement with leading private research university covering antibody therapeutic candidates

Share

Feedback Therapeutics negotiates license agreement with leading private research university covering antibody therapeutic candidates

April 2026

Client(s) Feedback Therapeutics LLC

Jones Day represented Feedback Therapeutics, LLC in negotiating a license agreement with a leading private research university for rights to antibody therapeutic candidates targeting a novel immune response modulator protein.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.